1. Home
  2. MIR vs CNS Comparison

MIR vs CNS Comparison

Compare MIR & CNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIR
  • CNS
  • Stock Information
  • Founded
  • MIR 2005
  • CNS 1986
  • Country
  • MIR United States
  • CNS United States
  • Employees
  • MIR N/A
  • CNS N/A
  • Industry
  • MIR Industrial Machinery/Components
  • CNS Investment Managers
  • Sector
  • MIR Technology
  • CNS Finance
  • Exchange
  • MIR Nasdaq
  • CNS Nasdaq
  • Market Cap
  • MIR 4.4B
  • CNS 4.2B
  • IPO Year
  • MIR N/A
  • CNS 2004
  • Fundamental
  • Price
  • MIR $19.65
  • CNS $74.87
  • Analyst Decision
  • MIR Strong Buy
  • CNS Hold
  • Analyst Count
  • MIR 4
  • CNS 3
  • Target Price
  • MIR $18.75
  • CNS $81.00
  • AVG Volume (30 Days)
  • MIR 3.5M
  • CNS 175.7K
  • Earning Date
  • MIR 07-31-2025
  • CNS 07-16-2025
  • Dividend Yield
  • MIR N/A
  • CNS 3.34%
  • EPS Growth
  • MIR N/A
  • CNS 18.98
  • EPS
  • MIR N/A
  • CNS 3.06
  • Revenue
  • MIR $870,200,000.00
  • CNS $529,174,000.00
  • Revenue This Year
  • MIR $6.45
  • CNS $5.81
  • Revenue Next Year
  • MIR $7.51
  • CNS $12.38
  • P/E Ratio
  • MIR N/A
  • CNS $24.36
  • Revenue Growth
  • MIR 7.25
  • CNS 8.82
  • 52 Week Low
  • MIR $9.11
  • CNS $68.99
  • 52 Week High
  • MIR $20.80
  • CNS $110.67
  • Technical
  • Relative Strength Index (RSI)
  • MIR 57.14
  • CNS 42.77
  • Support Level
  • MIR $19.73
  • CNS $73.47
  • Resistance Level
  • MIR $20.68
  • CNS $77.18
  • Average True Range (ATR)
  • MIR 0.62
  • CNS 1.48
  • MACD
  • MIR -0.16
  • CNS -0.20
  • Stochastic Oscillator
  • MIR 42.50
  • CNS 28.81

About MIR Mirion Technologies Inc.

Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.

About CNS Cohen & Steers Inc

Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests mainly in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for close to two thirds of its $79.3 billion in managed assets at the end of January 2024. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 42% (27%) of its managed assets (base management fees) from institutional clients, 45% (52%) from open-end funds, and 13% (21%) from closed-end funds.

Share on Social Networks: